Cash flow GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 14:52:16 10/02/2026 GMT			5-day change	1st Jan Change
2,144.50 ^GBX	-0.67%		+10.51%	+17.84%

11:29am	GSK's RSV Vaccine Arexvy Accepted for Regulatory Review in China for Older Adults	MT
10:18am	GSK RSV vaccine Arexvy accepted for review in China for adults over 60	AN

d013194f44980575577674959de8.O1fXNsPlhFnGZqy2hImko8-PgB8Rz5tzrx308NaXldY.cyK5G6CL7z-TB5WD8N3jjoPiuUgllvAG8C2ciIeixb1fCKRZu5LKP6gVzw

Published financial data: GSK PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	34.1B	34.11B	29.32B	30.33B	31.38B
Total Revenues	34.1B	34.11B	29.32B	30.33B	31.38B
Cost of Goods Sold, Total	10.89B	11.45B	9.41B	8.39B	8.84B
Gross Profit	23.21B	22.66B	19.92B	21.94B	22.53B
Selling General & Admin Expenses, Total	10.5B	10.19B	8.18B	9.16B	10.85B
R&D Expenses	4.68B	4.88B	5.15B	5.82B	6.08B
Other Operating Expenses	-455M	-373M	-737M	-1.44B	-584M
Other Operating Expenses, Total	14.73B	14.69B	12.6B	13.54B	16.35B
Operating Income	8.48B	7.97B	7.32B	8.4B	6.18B
Interest Expense, Total	-860M	-775M	-819M	-710M	-615M
Interest And Investment Income	39M	26M	62M	108M	132M
Net Interest Expenses	-821M	-749M	-757M	-602M	-483M
Income (Loss) On Equity Invest.	33M	33M	-2M	-5M	-3M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	-21M	-4M	-46M	-75M	-63M
EBT, Excl. Unusual Items	7.67B	7.25B	6.52B	7.72B	5.64B
Restructuring Charges	-1.53B	-628M	-321M	-382M	-354M
Gain (Loss) On Sale Of Investments	-242M	1M	256M	-121M	57M
Gain (Loss) On Sale Of Assets	3.01B	591M	215M	61M	246M
Asset Writedown	-263M	-322M	-296M	-398M	-314M
Legal Settlements	-231M	-52M	922M	-	-
Other Unusual Items	-1.45B	-1.39B	-1.66B	-817M	-1.79B
EBT, Incl. Unusual Items	6.97B	5.44B	5.63B	6.06B	3.48B
Income Tax Expense	580M	346M	707M	756M	526M
Earnings From Continuing Operations	6.39B	5.1B	4.92B	5.31B	2.95B
Earnings Of Discontinued Operations	-	-	10.5B	-	-
Net Income to Company	6.39B	5.1B	15.42B	5.31B	2.95B
Minority Interest	-639M	-711M	-460M	-380M	-376M
Net Income - (IS)	5.75B	4.38B	14.96B	4.93B	2.58B
Net Income to Common Incl Extra Items	5.75B	4.38B	14.96B	4.93B	2.58B
Net Income to Common Excl. Extra Items	5.75B	4.38B	4.46B	4.93B	2.58B
Per Share Items
Net EPS - Basic	1.44	1.1	3.71	1.22	0.63
Basic EPS - Continuing Operations	1.44	1.1	1.11	1.22	0.63
Basic Weighted Average Shares Outstanding	3.98B	4B	4.03B	4.05B	4.08B
Net EPS - Diluted	1.43	1.08	3.66	1.2	0.62
Diluted EPS - Continuing Operations	1.43	1.08	1.09	1.2	0.62
Diluted Weighted Average Shares Outstanding	4.03B	4.05B	4.08B	4.11B	4.14B
Normalized Basic EPS	1.04	0.95	0.9	1.1	0.77
Normalized Diluted EPS	1.03	0.94	0.88	1.08	0.76
Dividend Per Share	1	1	0.61	0.58	0.61
Payout Ratio	69.18	91.2	23.18	45.6	94.91
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	10.37B	9.9B	9.47B	10.3B	8.31B
EBITA	9.38B	8.92B	8.41B	9.41B	7.43B
EBIT	8.48B	7.97B	7.32B	8.4B	6.18B
EBITDAR	10.4B	9.92B	9.49B	10.33B	8.34B
Effective Tax Rate - (Ratio)	8.32	6.36	12.56	12.47	15.13
Total Current Taxes	1.27B	1.35B	1.49B	1.62B	1.55B
Total Deferred Taxes	-693M	-1B	-784M	-865M	-1.03B
Normalized Net Income	4.16B	3.82B	3.61B	4.45B	3.15B
Interest Capitalized	15M	16M	21M	36M	20M
Interest on Long-Term Debt	55M	47M	51M	74M	46M
Non-Cash Pension Expense	82M	50M	37M	73M	64M
Supplemental Operating Expense Items
Advertising Expense	1.78B	1.81B	735M	835M	851M
Selling and Marketing Expenses	1.78B	-	-	-	-
Research And Development Expense From Footnotes	5.1B	5.28B	5.49B	6.22B	6.4B
Net Rental Expense, Total	27M	20M	17M	27M	30M
Imputed Operating Lease Interest Expense	6.56M	4.93M	5.06M	8.26M	8.71M
Imputed Operating Lease Depreciation	20.44M	15.07M	11.94M	18.74M	21.29M
Stock-Based Comp., Other (Total)	393M	404M	346M	307M	344M
Total Stock-Based Compensation	393M	404M	346M	307M	344M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	6.29B	4.27B	3.72B	2.94B	3.87B
Short Term Investments	480M	614M	750M	450M	381M
Trading Asset Securities, Total	63M	77M	4.25B	2.3B	75M
Total Cash And Short Term Investments	6.84B	4.96B	8.72B	5.69B	4.33B
Accounts Receivable, Total	5.55B	6.25B	5.45B	5.9B	5.56B
Other Receivables	1.3B	1.21B	969M	1.08B	1B
Notes Receivable	11M	18M	11M	9M	7M
Total Receivables	6.86B	7.48B	6.43B	7B	6.58B
Inventory	6B	5.78B	5.15B	5.5B	5.67B
Prepaid Expenses	359M	315M	343M	355M	390M
Other Current Assets, Total	195M	133M	123M	108M	37M
Total Current Assets	20.25B	18.67B	20.77B	18.64B	17B
Gross Property Plant And Equipment	21.46B	20.7B	19.36B	19.59B	19.92B
Accumulated Depreciation	-10.45B	-10.02B	-9.74B	-9.63B	-9.84B
Net Property Plant And Equipment	11.01B	10.67B	9.62B	9.96B	10.07B
Long-term Investments	3.5B	2.28B	1.58B	1.22B	1.23B
Goodwill	10.6B	10.55B	7.05B	6.81B	6.98B
Other Intangibles, Total	29.82B	30.08B	14.32B	14.77B	15.52B
Deferred Tax Assets Long-Term	4.29B	5.22B	5.66B	6.05B	6.76B
Other Long-Term Assets, Total	974M	1.63B	1.16B	1.56B	1.91B
Total Assets	80.43B	79.1B	60.15B	59B	59.46B
Liabilities
Accounts Payable, Total	4.36B	4.54B	3.87B	3.72B	3.46B
Accrued Expenses, Total	8.73B	9.97B	4.04B	4.08B	4.06B
Short-term Borrowings	1.05B	707M	1.49B	893M	-
Current Portion of Long-Term Debt	2.45B	2.69B	2.3B	1.76B	2.18B
Current Portion of Leases	230M	203M	167M	156M	168M
Current Income Taxes Payable	545M	489M	471M	500M	703M
Unearned Revenue Current, Total	361M	307M	299M	222M	171M
Other Current Liabilities	4.43B	4.76B	10.19B	9.73B	10.95B
Total Current Liabilities	22.15B	23.67B	22.81B	21.07B	21.7B
Long-Term Debt	22.54B	19.76B	16.19B	14.15B	13.7B
Long-Term Leases	887M	812M	841M	1.05B	934M
Unearned Revenue Non Current	21M	85M	83M	254M	165M
Pension & Other Post Retirement Benefits	3.65B	3.11B	2.58B	2.34B	1.86B
Deferred Tax Liability Non Current	3.6B	3.56B	289M	311M	382M
Other Non Current Liabilities	6.78B	6.76B	7.25B	7.03B	7.63B
Total Liabilities	59.62B	57.76B	50.05B	46.21B	46.38B
Common Stock, Total	1.35B	1.35B	1.35B	1.35B	1.35B
Additional Paid In Capital	3.28B	3.3B	3.44B	3.45B	3.47B
Retained Earnings	7.29B	8.75B	4.79B	7.74B	8.77B
Comprehensive Income and Other	2.67B	1.66B	1.02B	805M	83M
Total Common Equity	14.59B	15.06B	10.6B	13.35B	13.67B
Minority Interest	6.22B	6.29B	-502M	-552M	-585M
Total Equity	20.81B	21.34B	10.1B	12.8B	13.09B
Total Liabilities And Equity	80.43B	79.1B	60.15B	59B	59.46B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.98B	4.01B	4.03B	4.06B	4.08B
ECS Total Common Shares Outstanding	3.98B	4.01B	4.03B	4.06B	4.08B
Book Value / Share	3.66	3.76	2.63	3.29	3.35
Tangible Book Value	-25.83B	-25.58B	-10.77B	-8.23B	-8.83B
Tangible Book Value Per Share	-6.48	-6.38	-2.67	-2.03	-2.16
Total Debt	27.15B	24.17B	20.99B	18.02B	16.99B
Net Debt	20.32B	19.21B	12.26B	12.33B	12.66B
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.1B	1.13B	1.36B	763M	103M
Debt Equivalent Oper. Leases	216M	160M	136M	216M	240M
Minority Interest, Total (Incl. Fin. Div)	6.22B	6.29B	-502M	-552M	-585M
Equity Method Investments, Total	364M	88M	74M	55M	96M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.17B	1.77B	1.58B	1.59B	1.36B
Inventories - Work In Process, Total	2.4B	1.89B	2.29B	2.45B	2.68B
Inventories - Finished Goods, Total	2.43B	2.12B	1.28B	1.46B	1.62B
Land - (BS)	7.21B	6.95B	6.39B	6.22B	6.12B
Machinery, Total	11.55B	11.3B	10.48B	10.34B	10.64B
Full Time Employees	94.07K	90.1K	69.4K	70.21K	68.63K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	151M	150M	91M	85M	99M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	5.75B	4.38B	14.96B	4.93B	2.58B
Depreciation & Amortization - CF	1.21B	1.2B	1.06B	1.08B	1.1B
Amortization of Goodwill and Intangible Assets - (CF)	896M	957M	1.09B	1.01B	1.24B
Depreciation & Amortization, Total	2.11B	2.15B	2.15B	2.09B	2.34B
Amortization of Deferred Charges, Total - (CF)	241M	225M	-	203M	211M
(Gain) Loss From Sale Of Asset	-3.26B	-606M	-221M	-12M	-159M
(Gain) Loss on Sale of Investments - (CF)	-69M	28M	-1M	-1M	-16M
Asset Writedown & Restructuring Costs	781M	523M	198M	360M	369M
(Income) Loss On Equity Investments - (CF)	-33M	-33M	2M	5M	3M
Stock-Based Compensation (CF)	381M	367M	346M	307M	344M
Net Cash From Discontinued Operations	-	-	769M	-	-
Other Operating Activities, Total	2.58B	714M	-9.44B	-257M	631M
Change In Accounts Receivable	-224M	-782M	-158M	-794M	298M
Change In Inventories	119M	25M	-269M	-424M	-294M
Change In Accounts Payable	225M	284M	494M	-15M	-179M
Change in Other Net Operating Assets	-159M	670M	-1.42B	377M	431M
Cash from Operations	8.44B	7.95B	7.4B	6.77B	6.55B
Capital Expenditure	-1.23B	-1.17B	-1.14B	-1.31B	-1.4B
Sale of Property, Plant, and Equipment	68M	143M	146M	28M	65M
Cash Acquisitions	-105M	-114M	-3.19B	-1.47B	-824M
Divestitures	259M	-17M	-43M	49M	-18M
Sale (Purchase) of Intangible assets	242M	-987M	-919M	-1.02B	-1.45B
Investment in Marketable and Equity Securities, Total	2.85B	334M	95M	1.78B	2.23B
Other Investing Activities, Total	70M	36M	-3.72B	346M	168M
Cash from Investing	2.16B	-1.78B	-8.77B	-1.6B	-1.23B
Short Term Debt Issued, Total	-	318M	1.02B	-	266M
Long-Term Debt Issued, Total	3.3B	-	1.02B	223M	1.08B
Total Debt Issued	3.3B	318M	2.05B	223M	1.34B
Short Term Debt Repaid, Total	-7.3B	-2.31B	-5.07B	-2.45B	-892M
Long-Term Debt Repaid, Total	-227M	-215M	-1.8B	-341M	-1.84B
Total Debt Repaid	-7.53B	-2.53B	-6.87B	-2.79B	-2.73B
Issuance of Common Stock	29M	21M	25M	10M	20M
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-3.98B	-4B	-3.47B	-2.25B	-2.44B
Common & Preferred Stock Dividends Paid	-3.98B	-4B	-3.47B	-2.25B	-2.44B
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-1.95B	-1.4B	9.09B	-837M	-910M
Cash from Financing	-10.13B	-7.59B	823M	-5.64B	-4.73B
Foreign Exchange Rate Adjustments	-39M	-29M	152M	-99M	-54M
Net Change in Cash	431M	-1.44B	-394M	-567M	545M
Supplemental Items
Cash Interest Paid	864M	786M	848M	766M	632M
Cash Income Tax Paid (Refund)	1.66B	1.29B	1.31B	1.33B	1.31B
Levered Free Cash Flow	8.05B	6.47B	4.95B	3.56B	4.9B
Unlevered Free Cash Flow	8.59B	6.95B	5.46B	4.01B	5.29B
Change In Net Working Capital	-1.52B	-1.35B	-454M	1.52B	-1.38B
Net Debt Issued / Repaid	-4.23B	-2.21B	-4.82B	-2.57B	-1.39B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.62	6.24	6.57	8.82	6.52
Return on Total Capital	10.95	10.65	11.95	16.97	12.7
Return On Equity %	32.62	24.18	31.31	46.38	22.8
Return on Common Equity	44.24	29.59	34.78	41.16	19.06
Margin Analysis
Gross Profit Margin %	68.06	66.42	67.92	72.34	71.81
SG&A Margin	30.8	29.87	27.89	30.19	34.59
EBITDA Margin %	30.41	29.04	32.29	33.98	26.49
EBITA Margin %	27.51	26.16	28.67	31.03	23.67
EBIT Margin %	24.88	23.35	24.97	27.71	19.71
Income From Continuing Operations Margin %	18.73	14.94	16.78	17.5	9.41
Net Income Margin %	16.86	12.85	51	16.25	8.21
Net Avail. For Common Margin %	16.86	12.85	15.21	16.25	8.21
Normalized Net Income Margin	12.19	11.19	12.32	14.66	10.03
Levered Free Cash Flow Margin	23.6	18.96	16.88	11.75	15.63
Unlevered Free Cash Flow Margin	25.18	20.38	18.62	13.21	16.85
Asset Turnover
Asset Turnover	0.43	0.43	0.42	0.51	0.53
Fixed Assets Turnover	3.06	3.15	2.89	3.1	3.13
Receivables Turnover (Average Receivables)	6.18	5.78	5.01	5.34	5.47
Inventory Turnover (Average Inventory)	1.82	1.94	1.72	1.58	1.58
Short Term Liquidity
Current Ratio	0.91	0.79	0.91	0.88	0.78
Quick Ratio	0.62	0.52	0.66	0.6	0.5
Operating Cash Flow to Current Liabilities	0.38	0.34	0.32	0.32	0.3
Days Sales Outstanding (Average Receivables)	59.23	63.1	72.8	68.34	66.89
Days Outstanding Inventory (Average Inventory)	200.7	187.68	212.03	231.58	231.04
Average Days Payable Outstanding	142.21	144.36	174.82	158.34	145.73
Cash Conversion Cycle (Average Days)	117.71	106.41	110.01	141.58	152.19
Long Term Solvency
Total Debt/Equity	130.48	113.27	207.87	140.82	129.8
Total Debt / Total Capital	56.61	53.11	67.52	58.48	56.48
LT Debt/Equity	112.58	96.4	168.73	118.84	111.85
Long-Term Debt / Total Capital	48.84	45.2	54.8	49.35	48.67
Total Liabilities / Total Assets	74.13	73.02	83.21	78.32	77.99
EBIT / Interest Expense	9.86	10.28	8.94	11.84	10.06
EBITDA / Interest Expense	12.32	13.06	11.56	14.78	13.86
(EBITDA - Capex) / Interest Expense	10.89	11.54	10.17	12.93	11.59
Total Debt / EBITDA	2.56	2.39	2.22	1.72	1.99
Net Debt / EBITDA	1.92	1.9	1.29	1.17	1.49
Total Debt / (EBITDA - Capex)	2.9	2.7	2.52	1.96	2.38
Net Debt / (EBITDA - Capex)	2.17	2.15	1.47	1.34	1.78
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.02	0.04	18.74	3.42	3.46
Gross Profit, 1 Yr. Growth %	1.08	-2.37	19.53	10.16	2.69
EBITDA, 1 Yr. Growth %	-0.79	-4.47	22.09	13.37	-19.32
EBITA, 1 Yr. Growth %	-0.58	-4.86	25.08	14.72	-21.09
EBIT, 1 Yr. Growth %	-0.95	-6.09	29.96	14.76	-26.41
Earnings From Cont. Operations, 1 Yr. Growth %	21.26	-20.23	39.96	7.86	-44.4
Net Income, 1 Yr. Growth %	23.77	-23.73	241.07	-67.05	-47.75
Normalized Net Income, 1 Yr. Growth %	-2.63	-8.14	25.89	23.04	-29.25
Diluted EPS Before Extra, 1 Yr. Growth %	23.22	-24.1	33.5	9.8	-48.12
Accounts Receivable, 1 Yr. Growth %	1.13	12.56	-12.71	8.31	-5.79
Inventory, 1 Yr. Growth %	0.82	-3.55	-11.02	6.84	3.11
Net Property, Plant and Equip., 1 Yr. Growth %	-2.72	-3.03	-9.86	3.5	1.16
Total Assets, 1 Yr. Growth %	0.93	-1.65	-23.96	-1.9	0.78
Tangible Book Value, 1 Yr. Growth %	-14.21	-1	-57.91	-23.54	7.22
Common Equity, 1 Yr. Growth %	27.9	3.21	-29.6	25.94	2.43
Cash From Operations, 1 Yr. Growth %	5.25	-5.79	-6.9	-8.58	-3.16
Capital Expenditures, 1 Yr. Growth %	-3.08	-4.4	20.32	14.96	6.47
Levered Free Cash Flow, 1 Yr. Growth %	60.67	-19.66	2.11	-28.03	37.63
Unlevered Free Cash Flow, 1 Yr. Growth %	54.49	-19.04	2.59	-26.65	31.98
Dividend Per Share, 1 Yr. Growth %	0	0	-38.75	-5.31	5.17
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.18	0.53	9.73	10.82	3.44
Gross Profit, 2 Yr. CAGR %	4.86	-0.66	8.14	14.75	6.36
EBITDA, 2 Yr. CAGR %	5.3	-2.04	8.12	15.26	-5.42
EBITA, 2 Yr. CAGR %	5.69	-2.07	8.85	18.33	-6.01
EBIT, 2 Yr. CAGR %	6.39	-1.44	10.01	22.13	-8.1
Earnings From Cont. Operations, 2 Yr. CAGR %	25.65	-1.65	-1.8	22.87	-22.56
Net Income, 2 Yr. CAGR %	25.97	-2.84	61.29	6.01	-58.51
Normalized Net Income, 2 Yr. CAGR %	3.99	-2.82	8.92	24.46	-6.71
Diluted EPS Before Extra, 2 Yr. CAGR %	25.1	-3.29	-4.96	21.07	-24.53
Accounts Receivable, 2 Yr. CAGR %	3.54	6.69	-0.88	-2.77	1.01
Inventory, 2 Yr. CAGR %	4.64	-1.39	-7.36	-2.5	4.96
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.24	-2.88	-6.51	-3.41	2.33
Total Assets, 2 Yr. CAGR %	17.69	-0.37	-13.52	-13.63	-0.57
Tangible Book Value, 2 Yr. CAGR %	15.97	-7.84	-35.44	-43.27	-9.46
Common Equity, 2 Yr. CAGR %	96.42	14.89	-14.76	-5.84	13.58
Cash From Operations, 2 Yr. CAGR %	0.12	-0.42	-6.35	-7.74	-5.91
Capital Expenditures, 2 Yr. CAGR %	-4.49	-3.75	7.5	17.61	10.63
Levered Free Cash Flow, 2 Yr. CAGR %	75.87	16.28	-5.67	-14.27	-0.47
Unlevered Free Cash Flow, 2 Yr. CAGR %	100.79	14.19	-5.3	-13.25	-1.61
Dividend Per Share, 2 Yr. CAGR %	0	0	-21.74	-23.84	-0.2
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.15	3.44	-4.58	7.59	8.31
Gross Profit, 3 Yr. CAGR %	3.61	2.39	-4.63	8.8	10.58
EBITDA, 3 Yr. CAGR %	6.25	1.94	-2.83	8.35	2.34
EBITA, 3 Yr. CAGR %	7	2.05	-3.32	9.87	3.38
EBIT, 3 Yr. CAGR %	8.07	2.05	-3.71	11.57	3.15
Earnings From Cont. Operations, 3 Yr. CAGR %	43.34	7.99	-2.25	1.32	-5.67
Net Income, 3 Yr. CAGR %	55.4	6.57	47.66	-5.01	-16.26
Normalized Net Income, 3 Yr. CAGR %	9.56	-0.23	-3.67	13.44	3.11
Diluted EPS Before Extra, 3 Yr. CAGR %	54.4	5.91	-1.92	-0.28	-8.73
Accounts Receivable, 3 Yr. CAGR %	5.9	6.46	-0.21	2.09	-3.79
Inventory, 3 Yr. CAGR %	2.57	1.83	-4.71	-2.85	-0.66
Net Property, Plant and Equip., 3 Yr. CAGR %	0.45	-1.18	-5.26	-3.28	-1.91
Total Assets, 3 Yr. CAGR %	12.57	10.86	-8.95	-9.81	-9.07
Tangible Book Value, 3 Yr. CAGR %	3.41	10.01	-29.03	-31.7	-29.86
Common Equity, 3 Yr. CAGR %	498.62	58.5	-2.42	-2.92	-3.16
Cash From Operations, 3 Yr. CAGR %	6.86	-1.89	-2.63	-7.1	-6.24
Capital Expenditures, 3 Yr. CAGR %	-7.42	-4.46	-3.32	9.93	13.77
Levered Free Cash Flow, 3 Yr. CAGR %	-13.41	35.45	1.15	-13.81	0.38
Unlevered Free Cash Flow, 3 Yr. CAGR %	-12.57	48.33	0.81	-13.03	-0.23
Dividend Per Share, 3 Yr. CAGR %	0	0	-15.08	-16.6	-15.19
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.35	4.11	-0.58	-0.32	-1.45
Gross Profit, 5 Yr. CAGR %	9.02	3.61	-0.93	0.78	-0.38
EBITDA, 5 Yr. CAGR %	19.94	7	1.84	1.96	-4.23
EBITA, 5 Yr. CAGR %	23.35	7.96	1.89	2.31	-4.41
EBIT, 5 Yr. CAGR %	27.2	8.54	1.73	2.31	-5.49
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.27	36.84	17.8	5.58	-10.94
Net Income, 5 Yr. CAGR %	-7.35	36.9	57.73	6.35	-11.13
Normalized Net Income, 5 Yr. CAGR %	27.32	6.78	2.71	2.95	-4.89
Diluted EPS Before Extra, 5 Yr. CAGR %	-7.91	36.02	23.02	5.64	-11.68
Accounts Receivable, 5 Yr. CAGR %	7.73	6.24	3.14	2.67	0.28
Inventory, 5 Yr. CAGR %	4.92	2.54	-1.52	0.08	-0.95
Net Property, Plant and Equip., 5 Yr. CAGR %	2.63	-0.25	-2.4	-2.08	-2.3
Total Assets, 5 Yr. CAGR %	8.52	6.01	1.3	0.32	-5.69
Tangible Book Value, 5 Yr. CAGR %	9.09	1.61	-14.36	-15.59	-21.76
Common Equity, 5 Yr. CAGR %	23.32	68.03	174.5	28.69	3.69
Cash From Operations, 5 Yr. CAGR %	26.86	4.12	1.36	-4.28	-3.96
Capital Expenditures, 5 Yr. CAGR %	-2.34	-5.35	-5.85	-0.45	2.03
Levered Free Cash Flow, 5 Yr. CAGR %	22.9	6.85	-16.78	6.48	0.5
Unlevered Free Cash Flow, 5 Yr. CAGR %	20.93	6.46	-15.72	13.47	-0.16
Dividend Per Share, 5 Yr. CAGR %	0	0	-9.34	-10.32	-9.41